Please login to the form below

Not currently logged in
Email:
Password:

GSK public-private partnership CTTV names director

Centre for Therapeutic Target Validation launched last year
Dr Jeffrey Barrett

The Centre for Therapeutic Target Validation (CTTV), the product of a GSK public and private partnership, has formally appointed Dr Jeffrey Barrett as the founding director.

The CTTV, produced from a partnership between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute, launched a year ago and uses genome-scale experiments and analysis to look at therapeutic targets and research into treatments.

Treatments areas focused on by the partnership include cancer, inflammatory bowel disease and respiratory disease, with a commitment to share its data openly with the scientific community.

Barrett has been involved in the CTTV since its creation in 2014 and will start in his new role as director from May 1.

Commenting on the CTTV, Barrett said: “We are applying methods and technologies available on the Wellcome Genome Campus to help pharmaceutical researchers focus their detailed studies of biological mechanisms and improve their methods for designing effective medicines.

“The CTTV blends the pharmaceutical industry's sense of enterprise and motion, an academic style that gives questions the time and patience they need, and public data services to integrate many layers of knowledge.”

Barrett is currently group leader at the Wellcome Trust Sanger Institute, where his research group analyses genomic variation in thousands of individuals to identify genetic risk factors for disease.

Dr Patrick Vallance, president of pharmaceuticals R&D at GSK, added: “Jeff brings to this key role scientific vision and profound expertise in human genetics and bioinformatics.

“His scientific skills, vision and leadership are what we need to continue to advance the work we do within the centre.”

Article by
Kirstie Pickering

3rd March 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics